Free Trial
NYSE:TDOC

Teladoc Health (TDOC) Stock Price, News & Analysis

Teladoc Health logo
$8.18 -0.02 (-0.24%)
Closing price 07/28/2025 03:59 PM Eastern
Extended Trading
$8.20 +0.02 (+0.24%)
As of 06:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Teladoc Health Stock (NYSE:TDOC)

Key Stats

Today's Range
$8.13
$8.32
50-Day Range
$6.82
$8.88
52-Week Range
$6.35
$15.21
Volume
5.05 million shs
Average Volume
6.55 million shs
Market Capitalization
$1.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.67
Consensus Rating
Hold

Company Overview

Teladoc Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

TDOC MarketRank™: 

Teladoc Health scored higher than 58% of companies evaluated by MarketBeat, and ranked 455th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on 7 buy ratings, 13 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Teladoc Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Teladoc Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Teladoc Health are expected to grow in the coming year, from ($1.16) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Teladoc Health is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Teladoc Health is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Teladoc Health has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Teladoc Health's valuation and earnings.
  • Percentage of Shares Shorted

    14.10% of the float of Teladoc Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Teladoc Health has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teladoc Health has recently increased by 14.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Teladoc Health does not currently pay a dividend.

  • Dividend Growth

    Teladoc Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.10% of the float of Teladoc Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Teladoc Health has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teladoc Health has recently increased by 14.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Teladoc Health has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.08 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Teladoc Health this week, compared to 7 articles on an average week.
  • Search Interest

    40 people have searched for TDOC on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $128,189.00 in company stock.

  • Percentage Held by Insiders

    Only 0.58% of the stock of Teladoc Health is held by insiders.

  • Percentage Held by Institutions

    76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Teladoc Health's insider trading history.
Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

TDOC Stock News Headlines

Teladoc (TDOC) Q2 Earnings Report Preview: What To Look For
Teladoc Health (NYSE:TDOC) Now Covered by Analysts at Mizuho
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Analyzing Teladoc Health (TDOC) & Its Rivals
See More Headlines

TDOC Stock Analysis - Frequently Asked Questions

Teladoc Health's stock was trading at $9.09 at the beginning of the year. Since then, TDOC stock has decreased by 10.0% and is now trading at $8.18.

Teladoc Health, Inc. (NYSE:TDOC) issued its earnings results on Wednesday, February, 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by $0.07. The health services provider earned $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative trailing twelve-month return on equity of 11.01% and a negative net margin of 39.66%.
Read the conference call transcript
.

The following companies are subsidiaries of Teladoc Health: Livongo, Intouch Health, MedecinDirect, TelaDietitian, Advance Medical, Best Doctors, CogCubed, and more.

Teladoc Health (TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health's top institutional shareholders include Robeco Institutional Asset Management B.V. (0.34%), Allianz Asset Management GmbH (0.32%), Bank Hapoalim BM (0.05%) and Counterpoint Mutual Funds LLC (0.02%). Insiders that own company stock include Jason N Gorevic, Laizer Kornwasser, Mala Murthy, Michael Willem Waters, Nikolaos P Nanis, Adam C Vandervoort, Stephany Verstraete, Arnnon Geshuri, Andrew Turitz, Thomas Mckinley, Karen L Daniel, Vidya Raman-Tangella, Daniel Trencher, Richard J Napolitano, Carlos Nueno, James L Cave, Claus Torp Jensen and Fernando M Rodrigues.
View institutional ownership trends
.

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Teladoc Health investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Salesforce (CRM), Advanced Micro Devices (AMD) and PayPal (PYPL).

Company Calendar

Last Earnings
2/26/2025
Today
7/28/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:TDOC
CIK
1477449
Fax
N/A
Employees
5,500
Year Founded
2002

Price Target and Rating

High Price Target
$12.00
Low Price Target
$7.00
Potential Upside/Downside
+18.2%
Consensus Rating
Hold
Rating Score (0-4)
2.35
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
($5.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.00 billion
Net Margins
-39.66%
Pretax Margin
-40.18%
Return on Equity
-11.01%
Return on Assets
-4.66%

Debt

Debt-to-Equity Ratio
0.70
Current Ratio
1.68
Quick Ratio
1.64

Sales & Book Value

Annual Sales
$2.55 billion
Price / Sales
0.56
Cash Flow
$5.56 per share
Price / Cash Flow
1.47
Book Value
$8.66 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
175,435,000
Free Float
174,417,000
Market Cap
$1.44 billion
Optionable
Optionable
Beta
1.84

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:TDOC) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners